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ABSTRACT 
Austin James Davies: Objective assessment of pseudoepitheliomatous hyperplasia                            
(Under the direction of Ricardo Padilla) 
 
 
 
 
 
 
 
Introduction: Most biopsy specimens are diagnosed by interpretation of glass slides. 
However, some conditions like pseudoepitheliomatous hyperplasia (PEH) and squamous cell 
carcinoma (SCCa) may have overlapping characteristics requiring additional testing. The aims of these 
studies were: 1- to examine an objective method to define the incidence of PEH in granular cell 
tumors (GCTs), and 2- to develop a process to differentiate PEH from SCCa. Methods: A definition of 
PEH in GCTs was formulated, interobserver agreement calculated, and the incidence of PEH in GCTs 
determined. We histomorphometrically measured and compared the proportions of cases with 
positive immunohistochemical marker. Results: Use of our definition of PEH resulted in a high level of 
agreement.  The proportion of melanocytes between PEH and SCCa cases was not significantly 
different. Conclusion: Our definition of PEH proved to be reliable and should be further validated. 
Melan-A is not capable of differentiating PEH and SCCa. 
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OBJECTIVE ASSESSMENT OF PSEUDOEPITHELIOMATOUS HYERPLASIA 
 
Introduction 
 
In the field of oral and maxillofacial pathology, the vast majority of lesions examined by the 
pathologist are diagnosed by using his or her expertise to interpret the material seen on a 
hematoxylin and eosin-stained (H&E) glass slide. While this is accurate the majority of the time, 
interpreting materials subjectively leaves room for differences in opinion and potentially introduces 
the possibility of misdiagnosis. The main goal of diagnostic specialties is to give the correct diagnosis. 
Occasionally, examination of H&E stained glass slides does not result in an accurate diagnosis and the 
pathologist is required to perform additional special tests. At the forefront of this endeavor are 
molecular and cytogenetic tests that allow for highly specific and sensitive results. However, these 
tests are costly and can delay treatment. In addition, generation of subjective data is difficult to 
replicate in independent studies. 
The first manuscript focuses on developing an objective operational definition of PEH in 
granular cell tumors (GCTs) and subsequently using it to determine its incidence in GCTs. The 
literature has widely varying reports of prevalence, but no standardized definition. The second 
manuscript aimed to objectively assess if there was a significant statistical difference between the 
proportions of cases that show marker expression in PEH versus SCCa, two occasionally confused but 
vastly different biologic entities.  
 2 
 
INCIDENCE OF PSEUDOEPITHELIOMATOUS HYERPLASIA IN ORAL GRANULAR CELL TUMORS OF 
ADULTS, AN INDEPENDENT RETROSPECTIVE ANALYSIS 
 
Introduction 
 
Granular cell tumor (GCT), also known as Abrikossoff's tumor, granular cell myoblastoma, 
granular cell nerve sheath tumor, and granular cell schwannoma, is an uncommon entity of soft tissue 
first described by Abrikossoff in 1926.(1) Consensus has not been reached whether the GCT 
represents a reactive, developmental, or neoplastic process; hence its multiple designations.(2) While 
rare malignant forms of GCTs have been described, it typically presents as a benign process.(3) In the 
past, theories for the tissue of origin of this tumor have included striated muscle, histiocytic, pericytic 
or fibroblastic origins. Current thinking suggests that these tumors arise from stem cells with neural 
crest differentiation, as supported by ultrastructural and immunohistochemical studies.(4,5) 
Clinically, the GCT can occur in any anatomic location. It can occur on the mucosa or 
epidermis, and case reports have reported lesions of the forearm, orbit, chest wall, gastrointestinal 
tract, and bronchus.(6-10)
 
 In the head and neck, the oral cavity is the most common site for GCTs, 
and of the intraoral ones, the tongue has the highest incidence of occurrence.(4) Tongue GCTs usually 
present on the dorsal surface as a painless, sessile, firm, nodule less than 1.5 cm in diameter.(3) Their 
color can vary, but in general, when close to the surface they appear yellowish with a normal surface 
texture. Other reported intraoral locations include: lateral tongue (15%), buccal mucosa (13%), palate 
(6%), upper lip (4%), lower lip (4%), gingiva/retromolar pad (4%), and floor of mouth (2%).(11) GCT is 
reported to occur at any age, but it is most commonly observed between the ages of 30 and 60 and 
occurs twice as commonly in women than men.(2)
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Histologically, GCTs are composed of cells with granular cytoplasm arranged in a syncytial 
pattern, often forming nests, and ribbons separated by fibrous septa. This separation can give the 
appearance of invasion when the lesion occurs adjacent to or within striated muscle. As the most 
widely used name implies, a granular appearance of the cellular cytoplasm is always present. 
Ultrastructural studies have demonstrated that these granules contain lysosomes with cellular 
myelin.(4,12)
 
Another occasional histological feature, and the concentration of this project, is the 
propensity of GCTs to induce pseudoepitheliomatous hyperplasia (PEH) of the overlying surface 
epithelium. (Figure 1.1) While the exact mechanism for the induction of PEH is unclear, it is seen in 
other head and neck lesions such as deep fungal infections with granulomatous inflammation.(13) It 
has also been reported that some cases of PEH have been confused with squamous cell carcinoma 
(SCCa) by unsuspecting or inexperienced pathologists.(14) 
  Observations in our iŶstitutioŶs͛ oral biopsy services lead us to believe that the incidence of 
PEH in GCTs was closer to one third of cases, and not consistent with the literature.(4,11,15,17-19) 
We also noted a lack of uniformity in the definitions of PEH.(15,20,21) Therefore the goals of this 
study were to develop a working definition of PEH in GCTs based on published definitions, and to 
objectively determine the incidence of PEH in oral GCTs in our institutions by means of an 
independent observer study. 
Material and Methods 
 
This studǇ ǁas approǀed ďǇ the UŶiǀersitǇ of North CaroliŶa at Chapel Hill͛s IŶstitutioŶal 
Review Board (IRB) with allowed oversight of the University of the Pacific Arthur A. Dugoni School of 
DeŶtistrǇ͛s arĐhiǀal ŵaterial (UNC IRB Study # 14-0776). All IRB procedures and regulations were 
followed during the entire project. 
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The databases of the Oral and Maxillofacial Pathology Laboratories of the University of North 
Carolina at Chapel Hill School of Dentistry and the University of the Pacific Arthur A. Dugoni School of 
Dentistry were queried for cases of GCTs. The inclusion criteria were: histopathologic diagnosis of 
GCT, reported anatomic location within the oral cavity, and the patient being over 21 years of age at 
the time of surgery for the lesion. The search yielded 70 cases from both institutions. The cases were 
reviewed for an accurate diagnosis of GCT. Subsequently, two board-certified Oral and Maxillofacial 
Pathologists were utilized as observers for this study, (R.P., D.C.). We developed a new, stringent 
definition to test the incidence of PEH in GCTs based on analysis of various definitions available in the 
current literature.(22,23) This modified working definition was: 
Significant elongation or downgrowth of histologically benign-appearing squamous epithelium 
in the form of rete pegs along the surface epithelium. The individual cells are very mature, and 
only occasional dyskeratosis is present, usually as a keratin pearl rather than individually 
keratinized cells. Long, broad, intertwining rete pegs and rete ridges, when cut tangentially, 
can give a false, but rather strong impression of invading malignant epithelial islands of 
squamous cell carcinoma. 
Our PEH definition was used to calibrate the observers by having them independently review 
two cases that complied with that definition, and two that did not. Figure 1.2 illustrates the 
histological criteria for the working definition. To calculate intra-observer and inter-observer 
reliability, five additional blinded ͞reliability͟ cases were evaluated independently by each of the 
examiners before the retrospective analysis, and the same ͞reliability͟ cases were evaluated by each 
observer after the retrospective analysis. 
After calibration, each observer was asked to apply our definition of PEH while evaluating the 
70 test cases we found between the two institutions. The observers had neither demographic 
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ďaĐkgrouŶd of the Đase or kŶoǁledge of the other oďserǀer͛s aŶsǁers. ‘esults ǁere taďulated, and an 
unweighted Kappa (κ) statistical agreement test was applied using SPSS software (IBM Corp. Released 
2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp). 
A FisĐher͛s tǁo ǁaǇ eǆaĐt test ǁas eŵploǇed to test for a statistiĐally significant difference, 
since in our study the majority of GCTs of the lateral tongue occurred in females. 
Results 
Calibration tests revealed complete intra-observer and inter-observer agreement.  
In 68 out of 70 cases, both observers agreed in their responses. (κ= 0.939)(SEκ= 0.043)(95% 
confidence interval: from 0.856 to 1.000) The interpretation of the Kappa agreement value was 
ĐoŶsidered ͚alŵost perfeĐt͛ ďǇ the LaŶdis aŶd KoĐh͛s staŶdards for the streŶgth of agreeŵeŶt.(24) 
These results are summarized in Table 1.1.  The two cases in which there was no observer consensus 
were further excluded from our analysis.  
Of the 68 included cases, 25 had PEH (36.76%). Women constituted 79.41% of our study 
population. The average age of our patients was 44.9 years (Table 1.2). Anatomically, the vast 
majority of the lesions were from the tongue, followed by the buccal mucosa, and the lower lip. In our 
series, 91.4% (64/70) of our cases occurred on the tongue and buccal mucosa; and 93.33% of lateral 
tongue GCTs occurred in females. This last finding did not reach statistical significance (p=0.167). 
When we considered exclusively PEH cases from the tongue, the dorsum was the most 
common location, followed by the lateral surfaces, and then the ventral surface. In our series, no GCTs 
were found in the gingiva, maxillary vestibule, mandibular vestibule, and upper lip.  
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Discussion 
 
We strongly believe that in order to accurately diagnose and determine the incidence of PEH, 
a standardized, reproducible, and universally applicable definition of this entity is necessary. Such a 
strong definition must be supported by objectively generated data. We believe our definition of PEH 
complies with the parameters mentioned above. We demonstrated that our definition had agreement 
between the two observers as they applied the definition independently to different GCTs and agreed 
in 68/70 (97%) of the cases. This lead to a Kappa value of .939 or ͞almost perfect͟ agreement when 
compared to chance.(53) Only in two cases was agreement not attained. (Figure 3) Case one (Figure 
3A) was a 51-year-old female with a GCT on the buccal mucosa. Observer one called it positive for PEH 
while observer two called it negative. This case had some elongation of the rete ridges and was 
interpreted differently by the two pathologists. Case two (Figure 3B) was a 43-year-old male with a 
GCT on the dorsal tongue. Observer one called it positive for PEH while observer two called it 
negative. This case had only minimal elongation of the epithelial rete pegs. This discrepancy in two 
cases highlights a frequent issue in the practice of pathology: the interpretation of subjective concepts 
or histological features. Ideally, all diagnostic parameters would be objective, but unfortunately, 
current technology is short of allowing this transition and we still often rely on the ͞skill͟ of the 
pathologist for subjective evaluation of some conditions and diagnoses. While the proposed definition 
fails to bring 100% agreement to the tissues in question, it does show that ͞skilled͟ pathologists could 
apply the same definition of PEH and reach a high level of agreement. While currently no definition of 
PEH is universal, one that gives strong intra- and inter-observer reliability, like the one offered in this 
paper, is worth considering for use in future projects. We encourage other investigators to test our 
proposed definition of PEH and its incidence in oral GCTs in order to standardize data generation. 
Our study revealed a 36.76% incidence of PEH in oral GCTs as measured by two independent 
observers applying our proposed definition of PEH in GCTs. This incidence differs with most of the 
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previously published data in the English literature.(4,11, 15,17-19) All previous studies failed to 
disclose or apply a detailed definition of PEH and also lacked explanations of how the presence of PEH 
was determined. These poteŶtial flaǁs iŶ ŵost of the preǀious studies͛ methodology were the reasons 
that lead us to hypothesize that the incidence of PEH in GCTs has been historically overestimated. In 
our opinion, consensus regarding PEH incidence in GCTs cannot be reached unless a tested and 
standardized definition of PEH is applied. A single study from 30 years ago did report a similar 
incidence to the one found in our cases, but unfortunately this study also failed to provide a definition 
of PEH and an explanation of how they determined PEH in their cases of GCTs.(16)  
The most significant misinterpretation of PEH would be a misdiagnosis of SCCa, such as 
reported by Lack et al. They reported a case where a misinterpretation of PEH was diagnosed as SCCa 
and resulted in a patient being over-treated unnecessarily with radium needle implants.(14)  
Our data confirms some of the published findings regarding the distribution of GCTs. The most 
common area in the oral cavity was the tongue, specifically the dorsum followed by the lateral 
border.(11,15,17) In fact, in our study and another(15), the frequency of GCTs on the dorsal tongue 
was higher than in all the other intraoral sites combined. Our results also support previous reports 
that at least two-thirds of the patients are female (79.41% in our study).  Similarly, the age range of 
GCTs between 30-60 years coincided with our cases average age of 44.99 years.(4,11,15-18) In our 
study, the majority of GCTs of the lateral tongue occurred in females (93.33%).  Our data indicated a 
predilection for females when considering GCTs of the lateral tongue exclusively. We therefore 
further analyzed this discrepancy in incidence, but found it not statistically significant.  
After conclusion of this project, we feel that a revised definition for determining PEH in GCTs 
could be:  
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Significant elongation or downgrowth of histologically benign-appearing squamous epithelium 
in the form of rete pegs below the standard depth of the oral epithelium. The individual cells 
appear very mature with only occasional dyskeratosis.  The dyskeratosis is usually present as 
keratin pearls rather than individually keratinized cells.   
This revised definition is more operational than our first version.  We encourage future 
projects to test it as well, to determine the incidence of PEH in GCTs. 
Conclusions 
Utilization of our proposed definition of PEH in GCTs yielded ͚alŵost perfeĐt͛ Kappa iŶter-
observer statistical reliability values. The incidence of PEH in oral GCTs in our independent 
retrospective analysis was 36.76%. We encourage further studies with larger case series to use the 
tested definition as well as the revised definition to further validate the true incidence of PEH in GCTs 
of the oral cavity of adults.  
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Tables 
 
Table 1.1 - Results of the independent analysis to determine presence (Yes) or absence  
(No) of pseudoepitheliomatous hyperplasia used to calculate the unweighted Kappa 
Statistic (κ) 
 
 
Observer 1 
 
 
 
Yes No Total 
Yes 25 0 25
*
 
No 2 43 45 
Total 27 43
*
 70 
 
* 
Number of observed agreements: 68/70 (97.14%) 
 
 
Table 1.2 - Results of the distribution of granular cell tumors (GCTs) and  
pseudoepitheliomatous hyperplasia (PEH) seen in the oral cavity of adults in this study  
 
Location 
Number of 
Cases 
Presence of 
PEH (%) 
Mean age* 
Percentage 
Females* 
Dorsal Tongue 35 15 (42.86) 45.34 77.14 
Lateral Tongue 15 4 (26.67) 41.4 93.33 
Ventral Tongue 6 1 (16.67) 45.17 66.67 
Buccal Mucosa 6 3 (50) 56.17 66.67 
Lower Lip 3 1 (33.33) 26 100 
Floor of Mouth 1 1 (100) 49 100 
Hard Palate 1 0 (0) 70 0 
Soft Palate 1 0 (0) 46 100 
Total 68 25 (36.76) 44.99 79.41 
 
*
 Average age and percentage female of patients with GCTs (with or without PEH)  
 
O
b
se
rv
e
r 
2
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Table 1.3 - Incidence of pseudoepitheliomatous hyperplasia (PEH) in oral mucosal  
granular cell tumors (GCTs) in current and past studies 
Previous author and year Incidence 
Worsaae et al. (1979) 28.57% 
Lack et al. (1980) 7.89% 
Chaudhry et al. (1984) ͞IŶ ŶearlǇ oŶe third…͟ 
Stewart et al. (1988) 45% 
Mirchandani et al. (1989) 8.57% 
Chrysomali et al. (2003) 67% 
Le et al. (2004)
 *
 100% 
Vered et al. (2008) 25% 
Current series. (2016) 36.76% 
 
                                      *
8/8 + for PEH, one case had PEH as ͞N/A͟ (19) 
 
 
 
 
 
  
 11 
 
Figures 
Figure 1.1 - Pseudoepitheliomatous hyperplasia  
 
Fig 1.1 - A granular cell tumor (GCT) with overlying pseudoepitheliomatous hyperplasia (PEH). Image 
has been colored enhanced for brightness 
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Figure 1.2 - Illustrated criteria for working definition 
 
Fig 1.2 - Illustrated criteria for working definition of PEH. A. Elongation of benign appearing squamous 
epithelium B. Keratin pearls C. Long broad, intertwining rete pegs and rete ridges D. Long rete pegs 
tangentially cut giving false impression of squamous cell carcinoma 
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Figure 1. 3 - Cases in which agreement was not met  
 
Fig 1.3 - A. and B. These two cases of granular cell tumors (GCTs) represent the only cases on which 
agreement between the observers were not met  
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DIFFERENTIATION OF PSEUDOEPITHELIOMATOUS HYERPLASIA FROM SQUAMOUS CELL 
CARICNOMA OF THE ORAL MUCOSA BY IMMUNOHISTOCHEMISTRY 
 
Introduction 
 
Histopathological evaluation of hematoxylin and eosin stained (H&E) glass slides of tissue 
specimens is considered the gold standard for diagnosing numerous pathologies. In the majority of 
cases, this is an appropriate and sufficient diagnostic method.  Occasionally, tissue artifacts and 
predictable histological variations are seen upon examination of H&E-stained glass slides. One such 
variation is pseudoepitheliomatous hyperplasia (PEH).  When pathologists are aware and recognize 
these variations, they are able to avoid errors, and even arrive at a more accurate diagnosis. (1,2) 
Unfortunately, the presence of artifacts or histological variations may also occasionally lead to 
misdiagnosis. A common pitfall that can have dire consequences is misinterpreting PEH as squamous 
cell carcinoma (SCCa).  
PEH is also known as ͞pseudocarcinomatous hyperplasia,͟ and is a reactive hyperplastic 
elongation of epithelium that occurs in association with a number of traumatic, infectious, neoplastic, 
and inflammatory conditions. It does not appear to arise de novo or without a causative factor.(3) 
Histologically PEH consists of a significant elongation or downgrowth of benign-appearing stratified 
squamous epithelium rete pegs.(Figure 2.1) The individual cells are very mature, appropriately 
differentiated, and only occasional dyskeratosis is present, usually as keratin pearls rather than 
individual cell keratinization. The long, broad, and intertwining rete pegs and rete ridges, when cut 
tangentially, can give a false, but rather strong impression of invading malignant epithelial islands of 
SCCa. The pathogenesis of PEH has yet to be elucidated but most investigations have revolved around 
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epidermal growth factor and transforming growth factor interactions with the surface epithelium.(4) 
Treatment of the underlying initiating factor of the PEH rather than PEH itself is recommended. This 
requires accurate differentiation of PEH from SCCa.  
SCCa is a clonal neoplastic proliferation of keratinocytes, arising from the surface stratified 
squamous epithelium, that invade through the basement membrane into the supporting connective 
tissue stroma. The neoplastic cells invade as islands and cords of tumor. On the skin, it is one of the 
most common cancers in humans, with approximately 700,000 new cases each year in the United 
States.(5) In the United States, each year there are approximately 45,700 new cases of oral and 
oropharyngeal SCCa, causing about 8,600 deaths.(6) Histologically, SCCa shows cords and invasive 
islands of malignant keratinocytes with cytological atypia and features of malignancy, such as 
pleomorphic nuclei, atypical mitoses, dyskeratosis, necrosis, anaplasia, and dedifferentiation.(7). PEH 
may share some of the epithelial architectural features as well as some histologic features of SCCa. 
(Figure 2.2)(8) In cases where not all the features of SCCa are readily apparent, subtle clues can be 
missed and an incorrect diagnosis can be given.(9) 
During the pathologic evaluation of oral mucosal lesions, one may see a number of different 
cells in the epithelium. Keratinocytes are the most numerous, and provide the structural foundation 
for the epithelium. Langerhans cells and melanocytes are also seen within the epithelium although 
observed with much less frequency and mostly with the aid of special stains or 
immunohistochemistry. Langerhans cells are found in the basal and spinous regions and function as 
antigen-presenting cells that intercept microbes, process them, and then present the newly formed 
antigen to a T-cell, thereby acting as a line of defense in the innate immune system.(10) Melanocytes 
are normally found in the basal layer of the epithelium and histologically appear as oval shaped cells 
with clear cytoplasm and dendritic processes. The function of melanocytes in the oral cavity is less 
clear. On the skin their role is apparent as they synthesize melanin, a pigment that protects surface 
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cells against damaging UV radiation. In the mouth, where UV effects are negligible, it has been 
hypothesized that oral melanocytes may play a role in antigen capture and processing.(11,12)  
Considering that PEH is a hyperplastic condition, we believe that the stratified squamous 
epithelium that comprises this phenomenon will contain a diverse cellular population that mirrors 
that of normal epithelium, including keratinocytes, melanocytes, and Langerhans cells. Conversely, 
since SCCa is a neoplastic clonal proliferation, we believe that it is most likely comprised of a single 
lineage population of clonal keratinocytes and will not have the same cellular diversity as the normal 
or hyperplastic stratified squamous epithelium that we expect to see in PEH. The goal of our study 
was to elucidate this potential difference by means of histomorphometric analysis on the proportion 
of melanocytes in each condition via immunohistochemistry (IHC).     
IHC relies on the concept that different cells in the body express different proteins or 
antigens.(13) With the basic biological concept of antigen-antibody coupling, it is possible to highlight 
cells or tissues that react to a specific antibody to see if a protein of interest is present.  Although IHC 
has been commonly used to help evaluate lesions, this is the first report in the literature of Melan-A 
being tested as a surrogate marker for melanocytes to help differentiate PEH from SCCa.  
The surrogate marker Melan-A, also known as MART-1 (melanoma antigen recognized by T 
cells 1), is a highly specific and sensitive IHC stain for melanocytes.(14) A well-known example of a 
surrogate marker is the tumor suppressor p16 protein for the detection of Human Papillomavirus 
(HPV) in neoplastiĐ Đells. HPV͛s Eϳ proteiŶ ďiŶds to aŶd iŶaĐtiǀates huŵaŶ retinoblastoma protein 
(pRB) whose function is to suppress p16 production, leading to an overproduction of p16 with 
subsequent surrogate marker positivity.(15) In our experiment, we suspected that the proportion of 
melanocytes would be higher in a cellularly diverse hyperplastic oral mucosal epithelial proliferation 
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(PEH), and would be diminished in a clonal, non-cellularly-diverse, keratinocyte neoplastic process 
(SCCa).(16) 
 The current study is not the first attempt to distinguish the two entities via IHC. As shown in 
Table 2.1, various reports by other groups using other antibodies yielded mixed results. Zarovnaya et 
al. showed success with immunohistochemistry for p53+, MMP-20, and E-cadherin antibodies; while 
multiple other groups showed negative results.(8,17-20) As stated by El-Khoury et al. in 2012 ͞…there 
is no consensus on a specific immunohistochemical panel that may aid in the differentiation between 
PEH and SCC and more research is needed in this field.͟(21) Because of the striking histologic 
similarity, subjective interpretation of the entities, drastically different treatment hinging on the 
correct diagnosis, and lack of definitive work in this area, we explored whether a specific IHC marker 
could help separate the two conditions. Our null hypothesis was: there is no significant statistical 
difference between the proportion of cases that show marker expression in PEH versus SCCa. Our 
alternate hypothesis was: there is a significant statistical difference between the proportion of cases 
that show marker expression in PEH versus SCCa. 
Methods 
This studǇ ǁas approǀed ďǇ the UŶiǀersitǇ of North CaroliŶa at Chapel Hill͛s IŶstitutioŶal 
Review Board (UNC IRB Study # 14-0776). 
The archives of the Oral and Maxillofacial Pathology Laboratory of the University of North 
Carolina at Chapel Hill School of Dentistry dating from 2005-2014 were queried for qualifying cases for 
our study. The search fields included ͞pseudoepitheliomatous hyperplasia͟, ͞pseudo-epitheliomatous 
hyperplasia͟, ͞pseudocarcinomatous hyperplasia͟, and the laďoratorǇ͛s retrieval code for PEH. The 
search yielded 80 cases of PEH. All cases were re-reviewed by a board certified oral and maxillofacial 
pathologist. Cases were excluded on three counts: if no additional tissue was available in our archives; 
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if no PEH could be detected in the last cut glass slide; or if the patient was a minor at the time of 
biopsy. 42 of the original eighty cases remained after the exclusion criteria were applied. 
The same protocol was followed to retrieve cases of SCCa. The search fields included 
͞squamous cell carcinoma͟ aŶd the laďoratorǇ͛s retrieval code for SCCa. All cases were re-reviewed by 
a board-certified oral and maxillofacial pathologist. The same exclusion criteria were used. 
For analysis, 42 cases of SCCa were matched to the 42 cases of PEH on the basis of age group, 
sex, and location for a total of 84. Age groups were originally divided as 18-54, 55-69, and >70 years. 
These age groups were adapted from a study by the Surveillance, Epidemiology, and End Results 
Program (SEER Program) from the National Cancer Institute.(22) For the purposes of tabulating the 
location of the lesions within the oral cavity, ten specific locations were defined as follows: gingiva, 
maxillary vestibule, mandibular vestibule, buccal mucosa, hard palate, soft palate, lateral tongue, 
dorsal tongue, ventral tongue, and floor of mouth.   
Immunohistochemical staining was performed using the Bond Fully-Automated Slide Staining 
System (Leica Microsystems Inc., Norwell, MA). Formalin-fixed, paraffin-embedded tissue sections 
were deparaffinized in a dewax solution and hydrated in a wash solution. Antigen retrieval for Melan 
A antibody (Leica Microsystems) was performed using an epitope retrieval solution at pH 9.0 for 20 
minutes. After pretreatment, anti-Melan A was applied for 15 minutes. Detection of Melan-A was 
performed using a polymer refine detection system. Stained slides were dehydrated and cover-
slipped. Positive and negative controls (no primary antibody) were included. Stained slides were 
digitally imaged at 20 × magnification using the Aperio ScanScope XT (Aperio Technologies, Vista, CA). 
Digital images were stored in the University of North Carolina Translational Pathology Laboratory 
(TPL) eSlide Manager Database (Aperio; https://tpl-spectrum.med.unc.edu) for subsequent 
histomorphometric analysis.  
 21 
 
All slides contained epithelium; a board certified pathologist was recruited to discern which 
areas of the slides were to be histomorphologically analyzed by the computer software. The 
pathologist was blinded to any knowledge of the case demographics, clinical information, diagnosis, 
etc. The pathologist͛s iŶstruĐtioŶs ǁere to plaĐe pre-drawn standard-area circles, on each of the 
digitalized Melan-A stained slides, on the five most concerning areas for possible SCCa. If there were 
less than five concerning areas, he would only place circles in the areas concerning for possible SCCa. 
If no questionable areas existed, then he would not place any circles on that slide. The digitally pre-
drawn standard area annotation circles were 0.5mm in diameter, which corresponds to the same area 
as a traditional microscopic high-power field (HPF).(23) 
The Tissue Studio software (version 2.4.2; Definiens Inc., Carlsbad CA) was then calibrated to 
record a positive finding. A positive finding was defined as any positive stain signal that surrounded a 
pale blue area of counter stain in any of the circled fields. This area represented the periphery of the 
nucleus of the melanocyte. The results for each case were reported in a binary fashion: 0 = no 
melanocytes present, and 1 = melanocytes present.(Figures 2.3 and 2.4) 
Due to lack of a high number of specimens for each of the age-sex-location matched pairs, the 
groups were re-assigned into broader, though still biologically relevant, groups: 1- gingiva and hard 
plate; 2 - maxillary vestibule, mandibular vestibule, buccal mucosa, soft palate, dorsal tongue, ventral 
tongue, lateral tongue, and floor of mouth. Due to small sample size, the age categories were also 
reassigned as: A - 18-55 years; and B - 56 years and older.  
 The data was then subjected to multiple MĐNeŵar͛s tests, and multiple conditional logistic 
regression tests (CLR) using SPSS software (IBM Corp. Released 2013. IBM SPSS Statistics for Windows, 
Version 22.0. Armonk, NY: IBM Corp). The level of significance was set at alpha = 0.05 for all tests. 
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Results 
The results are shown in detail on Tables 2.2 and 2.3. When calculated ďǇ MĐNeŵar͛s test, the 
proportion of Melan-A positive melanocytes between PEH and SCCa was not significantly statistically 
different for all cases and subgroups. Using CLR, an odds ratio (OR) of 2.75 was obtained when 
comparing all groups of PEH versus SCCa, but this value did not attain statistical significance (p=0.083). 
None of the subgroups were significantly statistically different.   
Discussion 
 The aim of this study was to attempt to differentiate between PEH and SCCa by measuring the 
proportions of melanocytes. Analysis of our data determined that there were no significant statistical 
differences when comparing PEH to SCCa in either statistical test of all groups. While this value did not 
attain statistical significance (p=0.083), an OR of 2.75 that compared all cases of PEH and SCCa was 
obtained using CLR, and interestingly the CLR values in Table 2.3 approached a closer statistical 
significance than in the MĐNeŵar͛s tests in Table 2.2. We believe that this difference may be in part 
due to the nature of the tests themselves, and also due to the incorporation of the Yates correction 
faĐtor to the MĐNeŵar͛s test iŶ “P““ in order to make the test more conservative.(24)  
 Another issue worth elaborating on is how our cases were selected and arranged. We 
matched our cases in 1:1 pairs. This pairings offered advantages in statistical power calculations due 
to low sample size, and addressed any possible cofounding variables.(25) The unquestionable 
disadvantage of pairing the data is that diagnostic tests calculations cannot be performed. Diagnostic 
tests include sensitivity, specificity, likelihood ratio (LR), positive predictive value (PPV), and negative 
predictive value (NPV). These calculations are the standard for how markers are compared to one 
another. If our experiment had showed promise, larger studies could be performed using independent 
samples from which diagnostic tests could be calculated. 
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 In regards to the IHC, multiple melanocytic markers are commercially available. We selected 
to use Melan-A in this project. The diagnostic test values for Melan-A are: 95%, 97%, 75, 97%, and 
94% in regards to sensitivity, specificity, LR, PPV, and NPV, respectively.  Another choice could have 
been microphthalmia associated transcription factor (Mitf), which has better or equal sensitivity, 
specificity, LR, PPV, and NPV at: 100%, 97%, 90, 97%, and 100% respectively.(Table 2.4)(26) Besides 
comparing diagnostic test values, one can also look at staining properties. Melan-A staining is 
constrained to the cytoplasm, while Mitf is constrained to the nucleus. This is important because the 
melanocyte is a dendritic cell that in cross section would show multiple apparently independent 
positive stains. If these stains were to all be counted, it would overestimate the true number of 
melanocytes. Conversely because cells were often cut in cross section, a total surrounding of the 
nucleus by the stain was not always possible. This then could have underestimated the number of 
melanocytes. Choosing Mitf would have allowed for any positive signal detected to be considered 
positive, potentially improving the objectiveness of the results. In summary, we believe that Mitf 
would be a better antibody to objectively evaluate for the number of melanocytes.  
 A previous publication by Zaronayva and Black reported success with immunohistochemical 
differentiation between PEH and SCCa.  Their IHC choices are shown in Table 2.1. They used 
independent samples and thus were able to report diagnostic utility for one of their markers, Matrix 
metalloproteinase-1 (MMP-1) with 81% sensitivity, 94% specificity, 93% PPV, and 84% NPV; LR was 
not calculated in that study.(Table 2.5)(8) In their study, the use of two observers allowed for cases of 
disagreement to be subjectively resolved, as opposed to ours, in which the determination of marker 
positivity was a completely objective and automated process. This controlled for some interobserver 
reliability errors, which are very common problems encountered in diagnostic pathology. 
 There are numerous examples of intra- and inter-observer variability in the practice of surgical 
pathology.(27-29) We believe that this is mainly due to the subjective diagnostic parameters used in 
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the interpretation of the material. IHC is also a procedure that usually needs the pathologist͛s 
interpretation, and is only occasionally interpreted in an automated fashion.(30) A new trend in 
pathology practice is cytogenetic and molecular testing of tissue.(31) These new tests do have more 
objective criteria and often yield binary data, creating an unequivocal result. As technology related to 
these tests advances, the ability to discern subjective difficult cases will likely improve.(32) This study 
attempted to take a step in that direction by trying to objectively differentiate between the 
proportion of melanocytes in PEH and SCCa. 
Conclusion 
We fail to reject our null hypothesis: there is no significant statistical difference between the 
proportion of cases that show marker expression in PEH versus SCCa.  
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Tables 
 
Table 2.1 - Published attempts of differentiating PEH from SCCa. 
Group Year IHC Helpful? 
Lee, YS et al. 1994 p54 No 
Sarda et al. 1995 AgNOR No 
Li et al. 1996 PCNA No 
Zarovnaya et. al 2005 
p53, MMP-1, E-Cad, 
Collagen IV 
Yes: p53, MMP-1, E-
Cad, No: Collagen IV 
Galan et al. 2007 CD1a No 
Davies et al. 2015 Melan-A No 
 
 
Table 2.2 - Results of the MĐNeŵar͛s tests 
Group P value Odds Ratio Confidence Interval 
All 0.118 2.75 0.8756-8.6365 
F 0.146 3 0.8122-11.0815 
M 1  *  * 
Age Group A 0.453  *  * 
Age Group B 0.289  *  * 
Location 1 0.687  * *  
Location 2 0.18 3.5 0.7271-16.8485 
                * = not calculated as α > 0.2 
 
Table 2.3 - Results of the conditional logistic regressions 
Group P Value Odds Ratio Confidence Interval 
All 0.083 2.75 0.876-8.636 
F 0.099 3 .812-11.081 
M 0.571 *  * 
Age Group A 0.273  *  * 
Age Group B 0.178 3 .606-14.864 
Location 1 0.423  * * 
Location 2 0.118 3.5 0.727-16.848 
            * = not calculated as α > 0.2 
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Table 2.4 - Results of the diagnostic test evaluations. 
 Melan-A Mitf Comparison 
Statistic Value  Value 
Sensitivity 95%  100% 
Specificity 97%  97% 
Likelihood Ratio 75  90 
Positive Predictive 
Value 
97% 97% 
Negative Predictive 
Value 
94% 100% 
                                    
 
 
Table 2.5 – Previous study by Zarovnaya and Black that successfully differentiated between PEH and 
SCCa using MMP-1 
Statistic Value 
Sensitivity 81% 
Specificity 94% 
Likelihood Ratio (*) 
Positive Predictive 
Value 
93% 
Negative Predictive 
Value 
84% 
                                                       *  Not reported 
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Figures 
 
Figure 2.1 - Pseudoepitheliomatous hyperplasia  
 
Fig 2.1 - Pseudoepitheliomatous hyperplasia (PEH) overlying a granular cell tumor (GCT). Image has 
been colored enhanced for brightness. 
 
 
 
 
 
 
 
 
Figure 2.2 – Squamous cell carcinoma 
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Fig 2.2 – Squamous cell carcinoma. Image has been colored enhanced for brightness 
 
 
 
 
 
 
 
 
 
 
 
 29 
 
Figure 2.3 – Immunohistochemical stain and cellular quantitative analysis in a positive marker 
example 
 
 
 
 
 
 
 
 
Fig 2.3- Immunohistochemical stain and cellular quantitative analysis in a positive marker example A. 
Immunohistochemical specimen containing melanocytes that are highlighted by the melanocytic 
marker Melan-A. B. Cellular analysis of all cells recognized by Tissue Studio software (version 2.4.2; 
Definiens Inc., Carlsbad CA). The ĐirĐle iŶdiĐates the pathologist͛s regioŶ of iŶterest. C. Cellular analysis 
of suspected melanocytes recognized by Tissue Studio software (version 2.4.2; Definiens Inc., Carlsbad 
CA) yielding a positive marker result. The ĐirĐle iŶdiĐates the pathologist͛s regioŶ of iŶterest. 
 
 
Figure 2.4 – Immunohistochemical stain and cellular quantitative analysis in a negative marker 
example 
 
 
 
 
 
 
 
 
Fig 2.4- Immunohistochemical stain and cellular quantitative analysis in a negative marker example A. 
Immunohistochemical specimen containing no detectable melanocytes by the melanocytic marker 
Melan-A. B. Cellular analysis of all cells recognized by Tissue Studio software (version 2.4.2; Definiens 
Inc., Carlsbad CA). The ĐirĐle iŶdiĐates the pathologist͛s regioŶ of iŶterest. C. Cellular analysis of of no 
melanocytes yielding a negative marker result. The ĐirĐle iŶdiĐates the pathologist͛s regioŶ of iŶterest. 
A B C 
A B C 
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